Moneycontrol PRO
you are here: HomeNewsIndia

Covid Globulin: Russia offers India new COVID-19 drug made out of plasma of recovered patients

Covid Globulin is produced from the blood plasma of people who either recovered from Covid or are fully vaccinated (got two jabs) against the coronavirus as such blood plasma contains the antibodies.

August 08, 2021 / 10:22 AM IST
Covid Globulin is produced from the blood plasma of people who either recovered from Covid or are fully vaccinated (got two jabs) against the coronavirus as such blood plasma contains the antibodies. [Image: Shutterstock]

Covid Globulin is produced from the blood plasma of people who either recovered from Covid or are fully vaccinated (got two jabs) against the coronavirus as such blood plasma contains the antibodies. [Image: Shutterstock]


Russia is keen to offer another advanced COVID-19 drug used for treatment in patients. Covid Globulin, the new drug is made out of plasma of recovered COVID-19 patients or who have received two doses of the vaccine.

The developer of Covid Globulin' drug, Russian major firm Rostec is willing to consider the supply and its domestic production in India, Rostec's CEO Sergey Chemezov told The Economic Times.

Covid Globulin is produced from the blood plasma of people who either recovered from Covid or are fully vaccinated (got two jabs) against the coronavirus as such blood plasma contains the antibodies. The drug neutralises the virus and its application helps the organism fight the disease and create the antibodies faster, said Chemezov, a close associate of Russian President Vladimir Putin.

Patients that receive the drug receive the plasma containing antibodies of the donor i.e. dedicated proteins produced by the immune system in response to the virus entering the human organism which helps neutralise the virus, he added.

"As soon as the drug passes all stages of clinical research, we will be ready to consider both orders from our Indian colleagues and potential production opportunities in India," he told the publication, adding that the firm's research confirmed the drug's safety, absence of side effects, and the ability to neutralise the virus.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The drug is reportedly intended to treat coronavirus and not prevent it.

"The Covid Globulin production process includes an up-to-date cleaning stage to ensure the drug’s highest safety and suitability for practically every patient, regardless of their age, blood group, or anamnesis," he said.
Moneycontrol News
first published: Aug 8, 2021 10:22 am

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark